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Exposure of cell lines endogenously expressing the thyroid hormone activating enzyme type 2 deio-
dinase (D2) to the chemical chaperones tauroursodeoxycholic acid (TUDCA) or 4-phenylbutiric acid
(4-PBA) increases D2 expression, activity and T3 production. In brown adipocytes, TUDCA or 4-PBA
induced T3-dependent genes and oxygen consumption (2-fold), an effect partially lost in D2
knockout cells. In wild type, but not in D2 knockout mice, administration of TUDCA lowered the
respiratory quotient, doubled brown adipose tissue D2 activity and normalized the glucose intoler-
ance associated with high fat feeding. Thus, D2 plays a critical role in the metabolic effects of chem-
ical chaperones.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction ER-stress response [6–8]. Thus, the ﬁnding that chemical chaper-Thyroid hormone accelerates energy expenditure with increases
in oxygen consumption of about 4-fold during the transition from
hypothyroidism to thyrotoxicosis [1,2]. Thyroid hormone is acti-
vated via the type 2 deiodinase (D2), with a number of molecules
accelerating D2-mediated conversion of T4 to T3 in metabolically
active tissues such as brown adipose tissue (BAT) and skeletal mus-
cle, including bile acids, xenobiotic compounds and insulin sensitiz-
ing agents [3]. Notably, disruption in the D2 pathway decreases
insulin signaling and/or energy expenditure [4,5].
D2 is an endoplasmic reticulum (ER)-resident protein with a
20-min half-life that is ubiquitinated by proteins involved in thechemical Societies. Published by E
itine palmitoyl transferase-1;
rotein 1; UCP-3, uncoupling
chondrial transcription factor
tor gamma coactivator 1a;
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this work.
, Programa de Bioquímica e
o, Cidade Universitária, Rio deones, which attenuate ER-stress, have been used in genetically ob-
ese mice to enhance insulin action and normalize metabolism [9]
led us to hypothesize an involvement of D2 in this process. Chem-
ical chaperones are small molecules known to stabilize protein
conformation in the ER. However, with the exception of alleviating
leptin resistance [10], it is not clear how 4-phenylbutyrate (4-PBA)
and taurine-conjugated ursodeoxycholate (TUDCA), the reported
chemical chaperones with metabolic activity, trigger their effects
on metabolism [11].
We now report that both TUDCA and 4-PBA are capable of acti-
vating the D2 pathway in a number of cell models and also when
administered to mice. Exposure of brown adipocytes to TUDCA or
4-PBA accelerates the production of T3 and stimulates energy
expenditure via a mechanism that is D2-dependent. In addition,
the use of D2 knockout (Dio2/) animals and cells indicate that
important metabolic effects resulting from treatment with TUDCA
also depend on the D2 pathway.
2. Materials and methods
2.1. Reagents and materials
Unless speciﬁed otherwise, all reagents were purchased from
Sigma Chemical Co. (St. Louis, MO) or Calbiochem (San Diego, CA).
Outer ring-labeled T4 (speciﬁc activity, 4,400 Ci/mmol) was fromlsevier B.V. All rights reserved.
540 W.S. da-Silva et al. / FEBS Letters 585 (2011) 539–544Perkin–Elmer (Boston,MA). Lipofectamine-Plus reagentswere from
Invitrogen (Carlsbad, CA). DMEM and RPMI-1640 were from GIBCO
(Grand Island, NY).
2.2. Animals
Animals were maintained and experiments performed according
to protocols approvedby theAnimal Care andUseCommittee in com-
pliance with National Institutes of Health standards. For all experi-
ments, 8-week old male mice were used. C57BL/6 J (C57) mice were
obtained from Jackson Laboratories (Bar Harbor, ME). Mice homozy-
gous for a targeted disruption of the Dio2 gene (Dio2/) on a C57
background were described previously [12]. Unless otherwise stated,
mice were fed normal chow and housed under a 12 h light/12 h dark
cycle at 22 C. Chow pellets (#5010) were from Lab Diet, MO and
high fat (TD.95121) pellets were obtained from Harlan Teklad, MA.
For calorimetric studies, mice were individually housed and
acclimated in calorimeter cages for 2 days followed by 2 days to ac-
cess baseline data and 7 days of data collection of gas exchanges
and food intake as described previously [13]. Body composition
was studied by dual energy X-ray absorptiometry (DEXA; Lunar
Piximus, Janesville, WI). For the procedure, mice were anesthetized
using Avertin (Tribromoethanol) 0.3–0.6 mg/g and placed on the
scan table for analysis [13].
2.3. Cells
Mesothelioma cells (MSTO-211H) and hepatocellular carcinoma
cells (HepG2) were purchased from ATCC (Manassas, VA). Cells
were grown and maintained in RPMI-1640 (MSTO-211H) andFig. 1. Tauroursodeoxycholic acid and 4-phenylbutyric acid stimulate D2 message, activ
500 lM TUDCA or 1000 lM 4-PBA for the indicated times. (B) Dose–response curve of D2
TUDCA. (C) T3 production in MSTO-211H cells treated for 48 h with TUDCA or 4-PBA
cyclohexamide for the indicated times. (E) Dio2 gene expression in MSTO-211H cells treat
experiments. #P < 0.05, ⁄P < 0.01, ⁄⁄P < 0.001, ⁄⁄⁄P < 0.0001 vs. vehicle treated cells.DMEM (HepG2), supplemented with 10% FBS and 100 nM sodium
selenite [14]. Brown adipocytes were differentiated in vitro from
isolated primary preadipocytes, as described previously [4]. Cellu-
lar Oxygen Consumption was measured in real-time using a XF-24
Extracellular Flux Analyzer (Seahorse Bioscience Inc., Billerica,
MA), as described previously [15].2.4. T4 to T3 conversion and deiodinase activity
The activities of type 1 and type 2 deiodinases (D1 and D2) were
measured as previously described [12]. The production of 125I from
outer ring-labeled T4, in intact cells was analyzed as described and
validated elsewhere [15].
2.5. Real-time qPCR
Total RNA was extracted using TRIzol reagent (Invitrogen) and
used to synthesize cDNA using SuperScript First-Strand Synthesis
System (Invitrogen). The RT-qPCR was performed as previously de-
scribed [15]. Cyclophilin A was used as a housekeeping gene.
2.6. Statistical analysis
All data were analyzed using PRISM software (GraphPad Soft-
ware, Inc., San Diego, CA) and are expressed as mean ± S.E.M.
One-way ANOVA was used to compare more than two groups, fol-
lowed by the Student–Newman–Keuls test to detect differences
between groups. The Student’s t-test (two-tailed) was used to com-
pare the differences between two groups; P < 0.05 was used to re-
ject the null hypothesis.ity and T3 production in intact cells. (A) D2 activity in MSTO-211H cells exposed to
activity in MSTO-211H cells treated for 24 h with the indicated amounts of 4-PBA or
at indicated doses. (D) D2 activity in MSTO-211H cells treated with 4-PBA and/or
ed for 24 h with 500 lM TUDCA or 1 mM 4-PBA. Values are the mean ± S.E.M. of 3–6
Table 1
D1 activity in HepG2 cells exposed to 4-PBA or TUDCA.
Treatment D1 activity (pmols/min⁄mg protein)
Vehicle 2.9 ± 0.05
500 lM TUDCA 2.7 ± 0.38
500 lM 4-PBA 2.5 ± 0.21
1000 lM 4-PBA 2.7 ± 0.05
Cells were treated for 24 h with vehicle (DMSO) or the indicated concentrations of
TUDCA or 4-PBA. Values are the mean ± S.E.M. of three different samples. All values
are not statistically different.
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3.1. Chemical chaperones increase D2 mRNA levels, protein levels and
T3 production
MSTO-211H cells, which endogenously express D2, were
exposed to increasing concentrations of TUDCA or 4-PBA forA B
D
Fig. 2. TUDCA and 4-PBA increase energy expenditure and modify gene expression in bro
exposed to increasing amounts of 4-PBA or 500 lM TUDCA for 24 h. (B) and (C), oxygen co
PBA for 48 h or 500 lM TUDCA for 24 or 72 h. (D) Relative mRNA levels in TUDCA or 4-PB
are the mean ± S.E.M. of 6–10 samples of at least two experiments. #P < 0.05, ⁄P < 0.01 o7–48 h, resulting in enhanced D2 activity (2.5–3-fold) as assayed
in cell sonicates (Fig. 1A and B). 4-PBA acted faster (maximum at
12 h), while the TUDCA effect lagged behind and reached its
maximum by 48 h (Fig. 1A). Similar results were observed in the
RMS-13 muscle cell line that endogenously expresses D2 as well
(data not shown). The effects were highly selective for D2 given
that the activity of D1, the other thyroid hormone activating deio-
dinase, remained unaffected in HEPG2 cells exposed to either
chemical chaperone (Table 1).
To study if D2 induction leads to increased T3 production in
intact cells, MSTO-211H cells were incubated with 125I-T4 and
125I-T3 production was analyzed. In this setting, it is clear that T3
production increases progressively (up to 3-fold) in response to
exposure to either one of the chaperones, in a concentration-
dependent fashion (Fig. 1C). Notably, D2 activity half-life was not
affected by 4-PBA (Fig. 1D; t1/2  47 min), which suggests a tran-
scriptional effect. In fact, treatment with TUDCA or 4-PBA in-
creased Dio2 mRNA levels between 1.5- and 3-fold, respectively
(Fig. 1E).C
0
wn adipocytes. (A) D2 activity in differentiated wild type primary brown adipocytes
nsumption in wild type or Dio2/ primary brown adipocytes treated with 1 mM 4-
A-treated wild type or Dio2/ primary brown adipocytes at indicated doses. Values
r ⁄⁄⁄P < 0.0001 vs. vehicle-treated cells.
Table 2
Serum concentrations of T4 and T3, D2 activity in BAT and pituitary gland of mice
treated with TUDCA.
Treatment D2 activity
(fmols/min mg protein)
T4 (ng/ml) T3 (ng/ml)
BAT–vehicle 1.9 ± 0.12 – –
BAT–TUDCA 4.3 ± 0.78* – –
Pit–vehicle 2.6 ± 0.73 – –
Pit–TUDCA 2.9 ± 0.64 – –
Serum–vehicle – 3.9 ± 0.61 0.56 ± 0.44
Serum–TUDCA – 4.3 ± 0.93 0.59 ± 0.69
Animals treated for 10 days with vehicle or TUDCA (0.5 mg/g BW) and tissues were
processed for D2 activity. Serum T4 and T3 were measured by RIA. Values are the
mean ± S.E.M. of ﬁve different animals.
* P < 0.05 vs. vehicle-treated animals.
542 W.S. da-Silva et al. / FEBS Letters 585 (2011) 539–5443.2. Chemical chaperones increase energy expenditure in primary
cultures of brown adipocytes
Induction of D2-generated T3 accelerates the rate of energy
expenditure in cell and animal models [15–18]. Here, we exposed
primary murine brown adipocytes to 4-PBA or TUDCA for 24 h,
with D2 activity increasing 3–5-fold in response to either chemical
chaperone (Fig. 2A). This induction was coincidental with acceler-
ation in the rate of oxygen consumption that took place between
24 and 72 h (Fig. 2B and C). Remarkably, this effect was greatly re-
duced (4-PBA; Fig. 2B) or abolished (TUDCA; Fig. 2C) when Dio2/A B
C D
Fig. 3. Impact of tauroursodeoxycholic acid on indirect calorimetry of wild type or Dio2/
mice on chow diet before and after treatment with 0.5 mg/g BW TUDCA for 7 days. For (A
the ﬁrst or last 24 h of treatment, and are presented as the mean ± S.E.M. of three animbrown adipocytes were used, indicating that D2 is a critical compo-
nent in the chemical chaperone-induced acceleration in energy
expenditure.
Next, we analyzed the expression of a number of metabolically
relevant genes in brown adipocytes treated with the chemical
chaperones. Exposure to either molecule increased the expression
of Ucp-1 and Ucp-3 by about 3-fold, whereas only treatment with
4-PBA induced Cpt-1, catalase, Glut-4 and Pgc-1a mRNA levels
(Fig. 2D). In the Dio2/ brown adipocytes, the induction of these
genes was markedly limited or abolished, with the exception of
Glut4 (Fig. 2D). Regardless of the cell type, both compounds were
only active when used at lM concentrations (Fig. 1A, B and 2A),
well within the range at which the metabolic effects of these mol-
ecules were reported [9]
3.3. D2 is critical for the metabolic improvement induced by chemical
chaperones in mice
Next, we studied the metabolic proﬁle of mice kept on a chow
diet and treated with 0.5 mg/kg BW TUDCA for 7 days. While treat-
ment with TUDCA failed to promote changes in body weight, body
composition and oxygen consumption (Table 3 and Fig. 3A and B),
it signiﬁcantly reduced the RQ of wild type mice by about 5%
(P < 0.05), indicating an increase in oxidation of fatty acids
(Fig. 3D). This effect was lost in the TUDCA-treated Dio2/ mice
(Fig. 3D). Food intake was only minimally affected by treatment
with TUDCA (Table 3). Accordingly, treatment with TUDCA was animals. Oxygen consumption (A and B) and respiratory quotient (RQ) (C and D) in
–D) all values were calculated as the area under the curve of measurements made on
als. In (D), P < 0.05 vs. Dio2/ by two-tail Student’s t-test.
Table 3
Body and food intake data of mice before and after treatment with TUDCA.
Parameter Dio2+/+ Dio2/
DBody weight gain (g) 1.57 ± 0.58 0.5 ± 0.53
DFood Intake (mg/g) 0.2 ± 0.59 0.51 ± 0.14*,**
Final body composition (% fat) 19.8 ± 1.9 17.9 ± 2.3
Animals were treated for 7 days with vehicle or TUDCA (0.5 mg/g BW) and body
weight and food intake were recorded daily and reported as the variation between
before and after treatment. Body composition was measured by DEXA. Values are
the mean ± S.E.M. of six different animals.
* P < 0.05 vs. vehicle-treated animals by Student’s t-test.
** P < 0.05 when paired Student’s t-test is used to compare the same animal before
and after treatment.
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itary gland D2 activity remained unchanged (Table 2). At the same
time, no substantial changes were detected in the T4 or T3 serum
concentrations of TUDCA-treated animals (Table 2). When placed
on a high fat diet for 3 weeks, both wild type and Dio2/ mice
developed glucose intolerance (Fig. 4A and B). As previously
reported [9], treatment with 0.5 mg/kg BW TUDCA normalized
glucose tolerance (Fig. 4A) but, remarkably, the same was not ob-
served in the Dio2/ animals (Fig. 4B).
4. Discussion
Given the observation that the chemical chaperones TUDCA and
4-PBA stimulate D2 activity via Dio2 mRNA accumulation (Fig. 1E)
and affect key metabolic genes in a D2-dependent manner (Fig. 2D)
we hypothesize that D2 is critical for the beneﬁcial metabolic ef-
fects associated with chemical chaperones action. Our results sup-
port this hypothesis and identiﬁed D2 as a key point targetable by
pharmacological intervention via the chemical chaperones. This is
also supported by our previous studies [5,15,18], indicating that
transcriptional induction of the Dio2 gene plays a metabolic role.
Here we expand this concept by providing a link between D2’s acti-
vation by chemical chaperones and cell-speciﬁc thyroid hormone
activation.
The expression of the Dio2 gene is regulated by several factors,
including NfkappaB [19] and cAMP [20,21], the latter being the
main player mediating the 5-fold increase in the D2 gene seen in
BAT during cold-induced adaptative thermogenesis [21]. D2 is also
regulated post-transcriptionally by structural destabilization fol-
lowed by ubiquitination [22–24]. Thus, it seemed logical to
hypothesize that chemical chaperones could stabilize D2 proteinFig. 4. Tauroursodeoxycholic acid improves glucose tolerance in wild type but not in Dio
fat diet. All values are the mean ± S.E.M. of 4 animals, where ⁄P < 0.01, ⁄⁄P < 0.001 and #Pand increase T3 production. However, both chemical chaperones
increased D2 activity and intracellular T3 production (Fig 1) based
on a Dio2 transcriptional response rather than prolongation of D2
protein turnover rate (Fig 1D). It is not clear what the underlying
mechanisms leading to increased Dio2 mRNA levels are, but TUD-
CA has been shown to activate major signaling pathways including
cAMP, PI3 kinase, p38 MAPK and ERK [18,25,26] whereas 4PBA is
implicated in the activation of C-JNK [27] and PPARgamma signal-
ing pathways [28], as well as in the regulation of heat shock pro-
tein [29] and anti-microbial peptides (AMPs) [30].
By accelerating D2 expression one would expect increased T3
production. Accordingly, exposure of brown adipocytes to either
4-PBA or TUDCA accelerated oxygen consumption (Fig. 2B and C)
and increased expression of metabolically relevant genes such as
Ucp-1, Ucp-3 and Pgc-1a (Fig. 2D), which are known to be T3
responsive [15,18]. This supports the concept that D2-expressing
cells treated with chemical chaperones have increased thyroid hor-
mone signaling. Remarkably, Dio2/ brown adipocytes were much
less sensitive to exposure to both chemical chaperones (Fig. 2B–D),
where most T3 responsive genes had a lesser induction and also a
limited acceleration of oxygen consumption (Fig. 2B). At the same
time, the fact that exposure to 4-PBA or TUDCA increased Glut4
expression in wild type and Dio2/ brown adipocytes (Fig. 2D)
indicates that this is not a T3-sensitive pathway and is likely to ex-
plain at least some of the metabolic effects of TUDCA in the Dio2/
animals (Fig. 4A and B).
These cellular data set the stage for in vivo studies with TUDCA,
which is suitable for in vivo administration [9,31]. D2 stimulation
in vivo was associated with a reduction in the RQ (Fig. 3C and D),
indicating increased fatty acid oxidation. This happened without
changes in serum T4 or T3 concentrations (Table 2), illustrating
the high tissue-speciﬁcity of D2-mediated mechanisms. Such as
observed previously [9], treatment with TUDCA improved systemic
glucose homeostasis in animals placed on a high fat diet (Fig. 4A).
Since these metabolic effects were minimized in the Dio2/ mice
(Fig. 4B), it is clear that D2 plays an important role in this process.
Because the global Dio2/ mouse was used in these experiments,
it is harder to identify the speciﬁc D2-expressing tissues targeted
by TUDCA that could be responsible for the metabolic phenotype.
However, BAT is a likely candidate given that brown adipocytes
and BAT respond to these chemical chaperones in vitro (Fig. 2; Ta-
ble 2), a tissue known for the interplay between D2, PGC1a and
UCP-1 [4].
In the present studies we linked D2-mediated T3 production
with acceleration of cellular oxygen consumption. In animals,2/ mice. Glucose tolerance test in WT (A) and Dio2/ (B) placed on a chow or high
< 0.05 vs. high fat diet group. These experiments were repeated at least two times.
544 W.S. da-Silva et al. / FEBS Letters 585 (2011) 539–544induction of D2 was associated with increased fatty acid oxidation
and improvement of glucose parameters. Given that BAT expresses
high levels of D2 one would attribute most of the D2-mediated ef-
fects of TUDCA to stimulation of BAT [15,18]. However, other D2-
expressing metabolically relevant tissues such as skeletal muscle
could be involved as well [5]. BAT and glucose homeostasis seem
to be particularly affected by thyroid hormone, probably due to
its effect to increase insulin signaling [32].
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